Sign In
Buy CASI
$0.208
+0 (+0%)
At Close: May 22, 2026
CASI Pharmaceuticals, Inc. (CASI) Reports Q2 Loss, Tops Revenue Estimates
12:35pm, Friday, 12'th Aug 2022 Zacks Investment Research
CASI Pharmaceuticals, Inc. (CASI) delivered earnings and revenue surprises of 13.85% and 19.70%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the sto
CASI Pharmaceuticals, Inc. (CASI) CEO Wei-Wu He on Q2 2022 Results - Earnings Call Transcript
12:28pm, Friday, 12'th Aug 2022
CASI Pharmaceuticals, Inc. (NASDAQ:CASI ) Q2 2022 Earnings Conference Call August 12, 2022 8:00 AM ET Company Participants Wei Zhang – Vice President Wei-Wu He – Chairman and Chief Executive Offic
CASI Pharmaceuticals, Inc. (CASI) Reports Q2 Loss, Tops Revenue Estimates
09:47am, Friday, 12'th Aug 2022
CASI Pharmaceuticals, Inc. (CASI) delivered earnings and revenue surprises of 13.85% and 19.70%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the sto
Why FlexShopper Surged Over 47%; Here Are 104 Biggest Movers From Yesterday
08:20am, Friday, 12'th Aug 2022 Benzinga
Gainers
Digital Media Solutions, Inc. (NYSE: DMS) jumped 78.8% to close at $2.11. Digital Media Solutions recently reported worse-than-expected Q2 EPS and sales results.
TOP Financial Group Limited (
Why Matterport Is Trading Higher By Around 25%, Here Are 73 Stocks Moving In Thursday's Mid-Day Session
05:49pm, Thursday, 11'th Aug 2022 Benzinga
Gainers
Timber Pharmaceuticals, Inc. (NYSE: TMBR) shares rose 63.8% to $0.1769. Timber Pharmaceuticals recently announced closing of $8.0 million public offering.
T2 Biosystems, Inc. (NASDAQ: TTOO) s
OptiNose (OPTN) Reports Q2 Loss, Misses Revenue Estimates
12:15pm, Thursday, 11'th Aug 2022 Zacks Investment Research
OptiNose (OPTN) delivered earnings and revenue surprises of -4.55% and 7.70%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
CASI PHARMACEUTICALS TO REPORT SECOND QUARTER 2022 FINANCIAL RESULTS AND HOST CONFERENCE CALL AUGUST 12, 2022
08:38am, Friday, 05'th Aug 2022
ROCKVILLE, Md. and BEIJING , Aug. 5, 2022 /PRNewswire/ -- CASI Pharmaceuticals, Inc. (Nasdaq: CASI), a U.S. biopharmaceutical company focused on developing and commercializing innovative therapeutics
Karyopharm Therapeutics (KPTI) Reports Q2 Loss, Tops Revenue Estimates
01:25pm, Thursday, 04'th Aug 2022 Zacks Investment Research
Karyopharm Therapeutics (KPTI) delivered earnings and revenue surprises of 1.59% and 9.08%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Why Is Yellow Trading Higher By 33%: Here Are 48 Stocks Moving Premarket
10:51am, Thursday, 04'th Aug 2022 Benzinga
Gainers
Missfresh Limited (NASDAQ: MF) shares rose 112.9% to $0.2450 in pre-market trading after dropping 7% on Wednesday.
GreenLight Biosciences Holdings (NASDAQ: GRNA) shares rose 100.6% to $6.54 i
Why Is CASI Pharmaceuticals (CASI) Stock Up 700% Today?
10:44am, Thursday, 02'nd Jun 2022
CASI Pharmaceuticals (CASI) stock rocketed higher in pre-market trading this morning but it's not due to any positive news from the company. The post Why Is CASI Pharmaceuticals (CASI) Stock Up 700% T
CASI Pharmaceuticals stock falls after reverse split takes effect
06:34am, Thursday, 02'nd Jun 2022
Shares of CASI Pharmaceuticals Inc. CASI, +18.01% are actually falling in premarket trading Thursday, as a 1-for-10 reverse stock split took effect. While some quote services may still be showing a bi
CASI Pharmaceuticals, Inc. (CASI) Reports Q1 Loss, Misses Revenue Estimates
12:15pm, Thursday, 12'th May 2022 Zacks Investment Research
CASI Pharmaceuticals, Inc. (CASI) delivered earnings and revenue surprises of 40% and 0.96%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
CASI Pharmaceuticals, Inc.'s (CASI) CEO Wei-Wu He on Q1 2022 Results - Earnings Call Transcript
11:32am, Thursday, 12'th May 2022
CASI Pharmaceuticals, Inc. (NASDAQ:CASI ) Q1 2022 Earnings Conference Call May 12, 2022 8:00 AM ET Company Participants Wei-Wu He - Chairman and Chief Executive Officer Wei Zhang - President Larry Zha
CASI Pharmaceuticals, Inc. (CASI) Reports Q1 Loss, Misses Revenue Estimates
09:47am, Thursday, 12'th May 2022
CASI Pharmaceuticals, Inc. (CASI) delivered earnings and revenue surprises of 40% and 0.96%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Corbus Pharmaceuticals (CRBP) Reports Q1 Loss, Lags Revenue Estimates
01:25pm, Tuesday, 10'th May 2022 Zacks Investment Research
Corbus Pharmaceuticals (CRBP) delivered earnings and revenue surprises of 11.11% and 100%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
